Viking Global Investors

Holding/activity history for  Intellia Therapeutics Inc. (NTLA)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2023   Q2 0 0 Sell 100.00% 0.28
2023   Q1 1,569,545 0.28 Reduce 22.35% 0.08 $37.27
2022   Q4 2,021,410 0.35 Add 7.01% 0.02 $34.89
2022   Q3 1,889,067 0.49 Reduce 15.23% 0.09 $55.96
2022   Q2 2,228,383 0.53 Reduce 9.74% 0.06 $51.76
2022   Q1 2,468,760 0.73 Add 56.30% 0.26 $72.67
2021   Q4 1,579,536 0.54 Add 23.45% 0.10 $118.24
2021   Q3 1,279,531 0.48 Add 31.22% 0.11 $134.15
2021   Q2 975,092 0.48 Buy 0.48 $161.91